Skip to main content
BKHA
NASDAQ Life Sciences

Black Hawk Buys One More Month with $150K Trust Deposit

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Neutral
Importance info
7
Price
$13.1
Mkt Cap
$54.412M
52W Low
$10.09
52W High
$13.1
52W Position info
30% above low
Off High info
at 52W high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

BKHA sits 30% above its 52-week low of $10.09 on light trading volume (0.2× avg).

Summary

Black Hawk Acquisition Corp deposited $150,000 to extend its SPAC merger deadline by one month to August 22, 2026, buying time to close the Vesicor Therapeutics deal despite severe financial and regulatory headwinds.


Key Events · Financing and Capital Events · BKHA

  • One-Month Extension Secured

    A $150,000 deposit into the trust account pushes the deadline for completing the initial business combination from July 22, 2026, to August 22, 2026.

  • Financial Impact

    Relative to the company's $54.4M market cap, the $150,000 payment is modest, yet it yields only a one-month extension of the runway.

  • Risk Context

    This extension arrives as the company grapples with a going concern warning, ineffective internal controls, and a Nasdaq delisting notice—all laid out in its July 15, 2026 10-Q.

  • Next Milestone

    By August 22, 2026, the merger with Vesicor Therapeutics must be completed, or the company faces the prospect of liquidation.


Analysis · BKHA · Life Sciences

To push its business combination deadline to August 22, 2026, Black Hawk placed $150,000 into its trust account. The move buys the SPAC precious time to finalize its merger with Vesicor Therapeutics, even as it wrestles with a going concern warning, ineffective internal controls, and a Nasdaq delisting notice. While the extension is a bid for survival, the modest sum and brief window highlight just how fragile the situation has become.

How filings like this one have moved

In the 30 days to Sep 10, 2026, 30.1% of the 2014 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.11%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BKHA was trading at $13.10 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $54.4M. The 52-week trading range was $10.09 to $13.10. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BKHA - Latest Insights

BKHA
Sep 04, 2026, 6:03 AM EDT
Filing Type: S-4/A
Importance Score:
8
Price at Filing: $11.99
Real-time Price: $11.99 info
Change: $0 (0%) info
Market Cap: $49.801M info
BKHA
Jul 31, 2026, 9:38 PM EDT
Filing Type: S-4/A
Importance Score:
9
Price at Filing: $11.78
Real-time Price: $11.99 info
Change: +$0.210 (+2%) info
Market Cap: $49.801M info
BKHA
Jul 15, 2026, 4:21 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $11.96
Real-time Price: $11.99 info
Change: +$0.030 (+0.25%) info
Market Cap: $49.801M info
BKHA
Jul 15, 2026, 4:20 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $11.96
Real-time Price: $11.99 info
Change: +$0.030 (+0.25%) info
Market Cap: $49.801M info
BKHA
Jul 02, 2026, 8:15 PM EDT
Filing Type: S-4/A
Importance Score:
9
Price at Filing: $11.91
Real-time Price: $11.99 info
Change: +$0.080 (+0.67%) info
Market Cap: $49.801M info